Effects of Parkinson's-Disease Mutation Reversed In Cells
An anonymous reader sends this quote from a press release at Eurekalert:
"UC San Francisco scientists working in the lab used a chemical found in an anti-wrinkle cream to prevent the death of nerve cells damaged by mutations that cause an inherited form of Parkinson's disease. A similar approach might ward off cell death in the brains of people afflicted with Parkinson’s disease, the team suggested in a study reported online in the journal Cell on August 15 (abstract). ... Mutations that cause malfunction of the targeted enzyme, PINK1, are directly responsible for some cases of early-onset Parkinson’s disease. Loss of PINK1 activity is harmful to the cell’s power plants, called mitochondria, best known for converting food energy into another form of chemical energy used by cells, the molecule ATP. In Parkinson’s disease, poorly performing mitochondria have been associated with the death of dopamine-producing nerve cells in a region of the brain called the substantia nigra, which plays a major role in control of movement. Loss of these cells is a hallmark of Parkinson’s disease and the cause of prominent symptoms including rigidity and tremor. A UCSF team led by Shokat, a Howard Hughes Medical Institute Investigator, used the chemical, called kinetin, to increase mutant PINK1 enzyme activity in nerve cells to near normal levels. 'In light of the fact that mutations in PINK1 produce Parkinson’s disease in humans, the finding that kinetin can speed mutated PINK1 activity to near normal levels raises the possibility that kinetin may be used to treat these patients,' Shokat said."
Back to the Future IV - Great Scott!
I am officially gone from
Since English isn't my mother tongue, there are times I find myself struggling to understand things others have written.
I have read, and re-read the following, which I copied from TFA:
'In light of the fact that mutations in PINK1 produce Parkinsonâ(TM)s disease in humans, the finding that kinetin can speed mutated PINK1 activity to near normal levels ...'
I dunno about you, but the more times I re-read the above the more confused I got
Well, it talks about the mitochondria "perform poorly". My guess is that the mutation somehow slows down the operation of the mitochondria, which would have been linked to Parkinsons. So my takeaway is that the kinetin speeds back up the operation of the mitochondria to close to non-mutated levels. But yes the summary is worded rather poorly.
The only thing necessary for evil to triumph is for it to be pitted against a slightly greater evil
See this site for some of the benefits of coconut oil: (Parkinson's is mentioned)
http://m.naturalnews.com/news/039388_coconut_oil_dementia_alzheimers_disease.html
In other words... they don't *actually* have any good news. They're just particularly hopeful that they will.
Sounds like somebody is using a particularly optimistic phrasing in order to get funding for more research.
Not to belittle such research, but until that research actually bears real fruit, it feels to me like they are deliberately trying to mislead people into thinking that a practical cure or treatment is basically here already (even though they don't actually come right out and say so), and to me that's not any better than the conmen who travelled from village to village in the 1700's selling "snake oil".
File under 'M' for 'Manic ranting'
This is not the first time that a protocol that restores energy metabolism, or protects it, has been found effective. And not just in early-onset Parkinson's. See for example the work of Birkmeyer who developed a protocol around NADH and Co-enyme Q10 (both co-enzymes active in glucose metabolism). Or the use of coconut oil (for the lauric acid contained therein) as a dietary addition to provide ketones as an alternative for glucose to energize cells: also found effective for many Alzheimers patients.
The ketogenic approach is easy to try as coconut oil is readily available. The Birkmeyer protocol requires a few supplements, in particular stablized NADH to be taken on an empty stomach.
The induction phase of the Atkins diet is mostly a ketogenic diet. For the treatment of epilepsy, there are now a handful of variations on the original ketogenic diet used since the 1920s, one of these is known as the "Modified Atkins".
However, there are stricter metabolic goals when on a ketogenic diet and special things to watch out for (too much protein can knock one out of ketosis, for example), so it is best to approach a ketogenic diet as a specialty topic in its own right rather than as something that a different low-carb diet may or may not achieve as a side effect.
There is a lot of recent research on the neuroprotective properties of a ketogenic diet, not just for Alzheimer's, but also for Parkinsons and stroke. See http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2367001/ for example.